PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Operating Income (Loss) in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2011 to Q3 2024.
  • Pacific Biosciences Of California, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$64.1M, a 22.3% increase year-over-year.
  • Pacific Biosciences Of California, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$409M, a 22.4% decline year-over-year.
  • Pacific Biosciences Of California, Inc. annual Operating Income (Loss) for 2023 was -$334M, a 8.88% decline from 2022.
  • Pacific Biosciences Of California, Inc. annual Operating Income (Loss) for 2022 was -$307M, a 46% decline from 2021.
  • Pacific Biosciences Of California, Inc. annual Operating Income (Loss) for 2021 was -$210M, a 102% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$409M -$64.1M +$18.4M +22.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$427M -$176M -$103M -140% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$325M -$81.4M +$9.89M +10.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$334M -$87.5M -$464K -0.53% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$334M -$82.5M -$7.87M -10.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$326M -$73.2M -$5.21M -7.66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$321M -$91.3M -$13.7M -17.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$307M -$87.1M -$22.4M -34.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$285M -$74.6M -$144K -0.19% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$285M -$68M -$30.4M -80.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$254M -$77.5M -$43.8M -130% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$210M -$64.7M -$40.7M -170% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$170M -$74.5M -$50.3M -208% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$119M -$37.6M -$14M -59.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$105M -$33.7M -$1M -3.06% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$104M -$24M -$6.06M -33.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$98.3M -$24.2M +$3.94M +14% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$102M -$23.5M +$856K +3.51% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$103M -$32.7M -$2.58M -8.55% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$101M -$17.9M +$12.7M +41.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-28
Q3 2019 -$113M -$28.1M -$3.44M -14% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 -$110M -$24.4M -$2.64M -12.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$107M -$30.1M -$6.19M -25.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$101M -$30.6M -$10.1M -49.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$90.9M -$24.7M -$3.1M -14.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$87.8M -$21.7M +$2.64M +10.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$90.4M -$23.9M -$650K -2.79% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$89.8M -$20.5M -$2.66M -14.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$87.1M -$21.6M -$4.83M -28.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 -$82.3M -$24.4M -$6.32M -35% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 -$76M -$23.3M -$4.73M -25.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 -$71.2M -$17.9M -$16.8M -1583% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 -$54.4M -$16.7M -$19.3M -740% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-26
Q2 2016 -$35.1M -$18.1M -$6.71M -59.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-26
Q1 2016 -$28.4M -$18.6M +$763K +3.95% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-26
Q4 2015 -$29.1M -$1.06M +$16.8M +94.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$46M $2.61M +$11M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 -$57M -$11.4M +$6.94M +37.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$63.9M -$19.3M -$1.08M -5.94% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$62.9M -$17.9M -$890K -5.23% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$62M -$8.41M +$11.5M +57.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$73.5M -$18.3M +$1.7M +8.48% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$75.2M -$18.2M +$2.36M +11.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 -$77.5M -$17M +$4.69M +21.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$82.2M -$19.9M +$2.64M +11.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$84.9M -$20M +$2.56M +11.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$87.4M -$20.6M +$6.9M +25.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 -$94.3M -$21.7M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$22.6M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$22.6M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$27.5M +$7.46M +21.3% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q1 2011 -$35M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.